Latest Posts › Private Equity

Share:

Healthcare Private Equity and COVID-19: Considerations as Provider Platforms Reopen

Businesses are starting to reopen as stay-at-home orders and business closures resulting from the novel coronavirus (COVID-19) begin to ease. Unfortunately, reopening likely will not be an immediate return to business as...more

Key Takeaways From the McGuireWoods Independent Sponsor Conference

On Oct. 2-3, McGuireWoods hosted its second annual Independent Sponsor Conference in Dallas, attended by more than 600 independent sponsors and capital providers from more than 35 U.S. states and Canada. ...more

Dermatology Spotlight Panel: 5 Key Points

The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference focuses on opportunities for investment in dermatology. Dermatology continues to be...more

Key Takeaways From the McGuireWoods Independent Sponsor Conference

On Oct. 5, McGuireWoods hosted its inaugural Independent Sponsor Conference in Dallas, attended by more than 300 independent sponsors and capital providers from more than 30 U.S. states. At the conference — the largest of its...more

Independent Sponsors: How to Leverage This Valuable Channel for Transactions

In an ultra-competitive deal market, investors continually look for attractive opportunities to deploy additional capital. While “independent sponsors” have been around for many years, the number of independent sponsors is at...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide